BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2216269)

  • 41. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases.
    Enders M; Weidner A; Zoellner I; Searle K; Enders G
    Prenat Diagn; 2004 Jul; 24(7):513-8. PubMed ID: 15300741
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reversion of the Ballantyne syndrome despite fetal hydrops persistence.
    Lobato G; Nakamura-Pereira M
    Fetal Diagn Ther; 2008; 24(4):474-7. PubMed ID: 19047795
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Severe fetal hydrops resulting from ABO incompatibility.
    Sherer DM; Abramowicz JS; Ryan RM; Sheils LA; Blumberg N; Woods JR
    Obstet Gynecol; 1991 Nov; 78(5 Pt 2):897-9. PubMed ID: 1923220
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Severe fetomaternal hemorrhage. A report of four cases.
    Moya FR; Perez A; Reece EA
    J Reprod Med; 1987 Mar; 32(3):243-6. PubMed ID: 3572910
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of fetal hemolytic disease by cordocentesis. II. Outcome of treatment.
    Weiner CP; Williamson RA; Wenstrom KD; Sipes SL; Widness JA; Grant SS; Estle L
    Am J Obstet Gynecol; 1991 Nov; 165(5 Pt 1):1302-7. PubMed ID: 1957851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Flow cytometric assessment of feto-maternal hemorrhage; a comparison with Betke-Kleihauer.
    Fernandes BJ; von Dadelszen P; Fazal I; Bansil N; Ryan G
    Prenat Diagn; 2007 Jul; 27(7):641-3. PubMed ID: 17441223
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Recurrence Risk of Fetomaternal Hemorrhage.
    Troìa L; Al-Kouatly HB; McCurdy R; Konchak PS; Weiner S; Berghella V
    Fetal Diagn Ther; 2019; 45(1):1-12. PubMed ID: 30223274
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term prognosis for infants after massive fetomaternal hemorrhage.
    Rubod C; Deruelle P; Le Goueff F; Tunez V; Fournier M; Subtil D
    Obstet Gynecol; 2007 Aug; 110(2 Pt 1):256-60. PubMed ID: 17666598
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Fetomaternal hemorrhage: practitioner's point of view].
    Huissoud C; Divry V; Rudigoz RC
    J Gynecol Obstet Biol Reprod (Paris); 2009 Jun; 38(4):286-97. PubMed ID: 19376657
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fetomaternal hemorrhage following funipuncture: increase in severity of maternal red-cell alloimmunization.
    Bowman JM; Pollock JM; Peterson LE; Harman CR; Manning FA; Menticoglou SM
    Obstet Gynecol; 1994 Nov; 84(5):839-43. PubMed ID: 7936523
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Persistent fetal hemoglobin in maternal circulation complicating the diagnosis of fetomaternal hemorrhage.
    Kush ML; Muench MV; Harman CR; Baschat AA
    Obstet Gynecol; 2005 Apr; 105(4):872-4. PubMed ID: 15802419
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of severe neonatal anemia due to fetomaternal transfusion.
    Naulaers G; Barten S; Vanhole C; Verhaeghe J; Devlieger H
    Am J Perinatol; 1999; 16(4):193-6. PubMed ID: 10458533
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Chronic fetomaternal transfusion].
    Rosegger H; Pickel H; Trittenwein G; Schober I
    Padiatr Padol; 1983; 18(4):393-7. PubMed ID: 6196707
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Doppler sonography for predicting fetal anemia caused by massive fetomaternal hemorrhage.
    Sueters M; Arabin B; Oepkes D
    Ultrasound Obstet Gynecol; 2003 Aug; 22(2):186-9. PubMed ID: 12905516
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fetal hemolytic anemia and intrauterine death caused by anti-M immunization.
    Wikman A; Edner A; Gryfelt G; Jonsson B; Henter JI
    Transfusion; 2007 May; 47(5):911-7. PubMed ID: 17465958
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Massive feto-maternal transfusion. Report of 3 cases with review of the literature].
    Boudier E; Langer B; Martinez C; Schumpp M; Treisser A; Schlaeder G
    J Gynecol Obstet Biol Reprod (Paris); 1999 Sep; 28(5):456-61. PubMed ID: 10566165
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Severe nonimmune hydrops fetalis and congenital corneal opacification secondary to human parvovirus B19 infection. A case report.
    Plachouras N; Stefanidis K; Andronikou S; Lolis D
    J Reprod Med; 1999 Apr; 44(4):377-80. PubMed ID: 10319311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Severe neonatal anemia due to fetomaternal hemorrhage: an ilustrative case].
    Menéndez Hernando C; Chacón Aguilar R; Fariñas Salto M; Pérez Crespo R; Martin Molina R; Moreno Novillo R; Cabrerizo Ortiz M
    Arch Argent Pediatr; 2019 Apr; 117(2):e142-e146. PubMed ID: 30869493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The incidence of large fetomaternal hemorrhage and the Kleihauer-Betke test.
    Pelikan DM; Scherjon SA; Kanhai HH
    Obstet Gynecol; 2005 Sep; 106(3):642-3; author reply 643. PubMed ID: 16135606
    [No Abstract]   [Full Text] [Related]  

  • 60. Massive fetomaternal hemorrhage: Manitoba experience.
    de Almeida V; Bowman JM
    Obstet Gynecol; 1994 Mar; 83(3):323-8. PubMed ID: 8127519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.